Deutsche Bank upgrades Biovail (NYSE: BVF) from Hold to Buy. Price target increased from $12 to $16.

Deutsche analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE